| Literature DB >> 31384261 |
Margarita Blanco-Cornejo1, Irma Luz Riva-Palacio-Chiang-Sam1, Iyari Sánchez-Díaz1, Antonio Cerritos1, Carlos Tena-Tamayo2, Daniel López-Hernández1.
Abstract
OBJECTIVE: To evaluate Mexico's national Integrated Management of Diabetes in Stages (Manejo Integral de la Diabetes por Etapas, MIDE) program using three types of indicators: process, structure, and impact.Entities:
Keywords: Americas; Mexico; Primary health care; delivery of health care; health care (public health); health policy; health promotion; health services
Year: 2017 PMID: 31384261 PMCID: PMC6645172 DOI: 10.26633/RPSP.2017.128
Source DB: PubMed Journal: Rev Panam Salud Publica ISSN: 1020-4989
Definitions and results for process, structure, and impact indicators used to evaluate the Integrated Management of Diabetes in Stages (MIDE) program, Mexico, 2007–2014
Indicator | Definition | Main result |
|---|---|---|
Process |
|
|
Metabolic variables |
|
|
Metabolic control (MetC) | Proportion (%) of patients with glycated hemoglobin (HbA1c) < 7.0% | 62% |
Average HbA1c reduction per patient | % decrease over study period | 25% reduction |
Average triglyceride reduction per patient | % decrease over study period | 31% reduction |
Average total cholesterol reduction per patient | % decrease over study period | 11% reduction |
Structure |
|
|
Medical services |
|
|
MIDE modules | Number installed in primary health care units of ISSSTE clinics | 140 modules installed |
Education program |
|
|
Training of health professionals | Health professionals awarded diplomas in three areas of vocational training | 1 117 diplomas awarded to 826 health professionals: 192 as diabetes educators 156 as diabetologists 151 as facilitators in organization, development, and group action on type 2 diabetes |
Patient empowerment | Patients accredited as “experts in diabetes” | 2 613 patients accredited |
Impact |
|
|
Medical outcomes |
|
|
Average number of illness days per patient | % decrease over study period | 38% reduction |
Average number of hospitalization episodes per patient | % decrease over study period | 41% reduction |
Manejo Integral de la Diabetes por Etapas, a primary health care program for diabetes patients at Institute for Social Security and Services for State Workers (Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, ISSSTE) hospital clinics and family medical clinics nationwide.
For the year 2013—the highest level of MetC recorded over the study period (MetC for 2014 was 60%).
Prepared by the authors based on the study results.
Proportion (%) of diabetes patients with metabolic control (MetC) after 3 or more months of participation in the Integrated Management of Diabetes in Stages (MIDE) program, by year, and relative change (±%), Mexico, 2007–2014
Year | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 |
|---|---|---|---|---|---|---|---|---|
% MetC (95% CI | 19.0% (19.2–19.4) | 35.4% (35.1–35.7) | 47.7% (47.2–47.9) | 50.1% (49.5–50.5) | 55% (54.6–55.5) | 60.1% (59.3–60.9) | 62% (61.1–62.5) | 60% (59.8–60.8) |
Relative change (±%) | ||||||||
2007 19.0% (19.2–19.4) | 0 | -16.4 (-16.3 to -16.5) | -28.7 (-28.6– -28.8) | -31.1 (-30.9– -31.2) | -36.0 (-35.9– -36.2) | -41.1 (-40.9– -41.2) | -43.0 (-42.9– -43.2) | -41.0 (-40.8– -41.3) |
2008 35.4% (35.1–35.7) | +16.4 (16.3–16.5) | 0 | -12.3 (-11.8– -12.8) | -14.7 (-14.2– -15.2) | -19.6 (-19.2– -20.0) | -24.7 (-24.3– -25.1) | -26.6 (-26.2– -27.0) | -24.6 (-24.3– -24.9) |
2009 47.7% (47.2–47.9) | +28.7 (28.6–28.8) | +12.3 (11.8–12.8) | 0 | -2.4 (-2.2– -2.6) | -7.3 (-7.0– -7.6) | -12.4 (-12.1– -12.7) | -14.3 (-14.0– -14.6) | -12.3 (-12.1– -12.5) |
2010 50.1% (49.5–50.5) | +31.1 (30.9–31.2) | +14.7 (14.2–15.2) | +2.4 (2.2–2.6) | 0 | -4.9 (-4.7– -5.1) | -10 (-9.8 to -10.2) | -11.9 (-11.7– -12.1) | -9.9 (-9.7– -10.1) |
2011 55% (54.6–55.5) | +36.0 (35.9–36.2) | +19.6 (19.2–20.0) | +7.3 (7.0–7.6) | +4.9 (4.7–5.1) | 0 | -5.1 (-4.9– -5.3) | -7.0 (-6.8– -7.2) | -5.0 (-4.9 to -5.1) |
2012 60.1% (59.3–60.9) | +41.1 (40.9–41.2) | +24.7 (24.3–25.1) | +12.4 (12.1–12.7) | +10 (9.8–10.2) | +5.1 (4.9–5.3) | 0 | -1.9 (-1.8– -2.0) | +0.1 (0.010–0.11) |
2013 62% (61.1–62.5) | +43.0 (42.9–43.2) | +26.6 (26.2–27.0) | +14.3 (14.0–14.6) | +11.9 (11.7–12.1) | +7.0 (6.8–7.2) | +1.9 (1.8–2.0) | 0 | +2.0 (1.9–2.1) |
2014 60% (59.8–60.8) | +41.0 (40.8–41.3) | +24.6 (24.3–24.9) | +12.3 (12.1–12.5 | +9.9 (9.7–10.1) | +5.0 (4.9–5.1) | -0.1 (-0.010– -0.11) | -2.0 (-1.9– -2.1) | 0 |
Prepared by the authors using information from the national MIDE administrative database.
Glycated hemoglobin (Hb1Ac) < 7%).
Manejo Integral de la Diabetes por Etapas, a primary health care program for diabetes patients at Institute for Social Security and Services for State Workers (Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, ISSSTE) hospital clinics and family medical clinics nationwide.
All P values calculated using one-way analysis of variance (ANOVA). Means compared using the Tamhane T2 post-hoc test. P values < 0.001 except for the comparison between the years 2012 and 2014.
Confidence interval.
P value > 0.001.
FIGURE 1.Number of patients participating in the Integrated Management of Diabetes in Stages (MIDE) program,a Mexico, 2007–2014
FIGURE 2.Number of clinics incorporated into the Integrated Management of Diabetes in Stages (MIDE) program (i.e., MIDE modules installed in ISSSTE primary care units) cumulatively (red) and by year (blue), Mexico, 2007–2014
FIGURE 3.Percentage of diabetes patients with metabolic control (MetC)a after 3 or more months of participation in the Integrated Management of Diabetes in Stages (MIDE) program,b Mexico, 2007–2014